Publication | Closed Access
Trilostane, an inhibitor of 3β-hydroxysteroid dehydrogenase, has an agonistic activity on androgen receptor in human prostate cancer cells
15
Citations
15
References
2010
Year
Molecular PharmacologyAndrogen ReceptorEndocrine-related CancerBiochemistryMedicineHormonal ReceptorPharmacotherapyAgonistic ActivityProstatic DiseaseEndocrinologyPharmacologySteroid Metabolism3β-Hydroxysteroid DehydrogenaseDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1